- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Inogen Inc (INGN)
Assess today's live Inogen Inc (INGN) share price, performance and insights using our live NASDAQ: INGN stock exchange data.
Analyse the historical data and Inogen Inc share price performance charts on this page. Our technical summary section provides analysis on Inogen Inc share price buy/sell indicators using real-time data (or discuss the Inogen Inc (INGN) stock price today with other investors in the Inogen Inc NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ INGN share price (ISIN: US45780L1044) to enhance your trading decisions with our free investment tools and resources.
What Is the Inogen Inc Share Price Today?
The Inogen Inc share price today is 5.89.
What Is the Stock Symbol for Inogen Inc
The stock symbol (or 'ticker') for Inogen Inc is "INGN."
What Stock Exchange Does Inogen Inc Trade On?
Inogen Inc is listed and trades on the NASDAQ stock exchange.
Is Inogen Inc a Good Stock to Buy?
Determining whether Inogen Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Inogen Inc share price performance charts on this page. Our technical summary section provides analysis on Inogen Inc share price buy/sell indicators using real-time data (or discuss the Inogen Inc (INGN) stock price today with other investors in the Inogen Inc NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ INGN share price (ISIN: US45780L1044) to enhance your trading decisions with our free investment tools and resources.
What Is the Inogen Inc Share Price Today?
The Inogen Inc share price today is 5.89.
What Is the Stock Symbol for Inogen Inc
The stock symbol (or 'ticker') for Inogen Inc is "INGN."
What Stock Exchange Does Inogen Inc Trade On?
Inogen Inc is listed and trades on the NASDAQ stock exchange.
Is Inogen Inc a Good Stock to Buy?
Determining whether Inogen Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
5.89
+0.03(+0.51%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.82
5.94
52 wk Range
5.70
12.91
INGN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.825.94
52 wk Range
5.7012.91
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
INGN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
13.00
Upside
+120.71%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Inogen Inc Company Profile
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Inogen Inc Earnings Call Summary for Q3/2025
- Inogen Q3 2025 reported EPS of -$0.20 (beating -$0.21 forecast) with revenue of $92.39M (0.94% below expectations), while maintaining positive adjusted EBITDA for the third consecutive quarter.
- Despite revenue miss, stock rose 2.23% to $8.24 in premarket trading, with international B2B revenue growing 18.8% YoY while direct-to-consumer sales declined 17.9% YoY.
- Company maintained full-year revenue guidance of $354-357M (6% YoY growth) and raised adjusted EBITDA guidance to $2M, with Q4 revenue expected between $87-90M.
- Inogen launched the Voxy 5 stationary oxygen concentrator, with sales impact expected in 2026, while continuing to advance reimbursement efforts for Symbiox product.
- CEO Kevin Smith emphasized international expansion as a 'key pillar' of long-term growth strategy, despite challenges from declining direct-to-consumer sales and gross margin pressure.
Last Updated: 05/11/2025, 14:22
Read Full TranscriptCompare INGN to Peers and Sector
Metrics to compare | INGN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipINGNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.3x | −3.1x | −0.6x | |
PEG Ratio | −0.11 | −0.20 | 0.00 | |
Price/Book | 0.8x | 4.8x | 2.6x | |
Price / LTM Sales | 0.5x | 3.8x | 3.4x | |
Upside (Analyst Target) | 121.8% | 60.7% | 43.4% | |
Fair Value Upside | Unlock | 17.3% | 6.3% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 13.00
(+120.71% Upside)
Earnings
Latest Release
Nov 05, 2025
EPS / Forecast
-0.20 / -0.21
Revenue / Forecast
92.39M / 93.27M
People Also Watch
FAQ
What Is the Inogen Inc (INGN) Share Price Today?
The live Inogen Inc share price today is 5.89
What Stock Exchange Does Inogen Inc (INGN) Trade On?
Inogen Inc is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Inogen Inc?
The stock symbol (also called a 'ticker') for Inogen Inc is "INGN."
What Is the Current Inogen Inc Market Cap?
As of today, Inogen Inc market capitalisation is 159.36M.
What Is Inogen Inc's (INGN) Earnings Per Share (TTM)?
The Inogen Inc EPS is currently -0.98 (Trailing Twelve Months).
When Is the Next Inogen Inc Earnings Date?
Inogen Inc's next earnings report will be released on 24 Feb 2026.
Is INGN a Buy or Sell From a Technical Analyst Perspective?
Based on today's Inogen Inc moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Inogen Inc Stock Split?
Inogen Inc has split 0 times. (See the INGN stock split history page for full effective split date and price information.)
How Many Employees Does Inogen Inc Have?
Inogen Inc has 766 employees.
What is the current trading status of Inogen Inc (INGN)?
As of 29 Jan 2026, Inogen Inc (INGN) is trading at a price of 5.89, with a previous close of 5.86. The stock has fluctuated within a day range of 5.82 to 5.94, while its 52-week range spans from 5.70 to 12.91.
What Is Inogen Inc (INGN) Price Target According to Analysts?
The average 12-month price target for Inogen Inc is USD13.00, with a high estimate of USD14 and a low estimate of USD12. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +120.71% Upside potential.
What Is the INGN Premarket Price?
INGN's last pre-market stock price is 6.08. The pre-market share volume is 390.00, and the stock has decreased by 0.22, or 3.75%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.